157 related articles for article (PubMed ID: 10368879)
1. Effect of fluvastatin in combination with moderate endurance training on parameters of lipid metabolism.
Wittke R
Sports Med; 1999 May; 27(5):329-35. PubMed ID: 10368879
[TBL] [Abstract][Full Text] [Related]
2. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
3. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
4. Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia.
Betteridge DJ; Durrington PN; Fairhurst GJ; Jackson G; McEwan MS; McInnes GT; Miller JP; Mir MA; Reckless JP; Rees-Jones DI
Am J Med; 1994 Jun; 96(6A):45S-54S. PubMed ID: 8017467
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.
März W; Scharnagl H; Abletshauser C; Hoffmann MM; Berg A; Keul J; Wieland H; Baumstark MW
Circulation; 2001 Apr; 103(15):1942-8. PubMed ID: 11306521
[TBL] [Abstract][Full Text] [Related]
7. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
[TBL] [Abstract][Full Text] [Related]
8. The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment.
Riegger G; Abletshauser C; Ludwig M; Schwandt P; Widimsky J; Weidinger G; Welzel D
Atherosclerosis; 1999 May; 144(1):263-70. PubMed ID: 10381299
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
[TBL] [Abstract][Full Text] [Related]
10. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
11. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.
Ballantyne CM; Herd JA; Ferlic LL; Dunn JK; Farmer JA; Jones PH; Schein JR; Gotto AM
Circulation; 1999 Feb; 99(6):736-43. PubMed ID: 9989957
[TBL] [Abstract][Full Text] [Related]
12. Effects of alcohol and fluvastatin on lipid metabolism and hepatic function.
Smit JW; Wijnne HJ; Schobben F; Sitsen A; De Bruin TW; Erkelens DW
Ann Intern Med; 1995 May; 122(9):678-80. PubMed ID: 7702230
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
[TBL] [Abstract][Full Text] [Related]
14. Effect of diet and fluvastatin treatment on the serum lipid profile of kidney transplant, diabetic recipients: a 1-year follow up.
Földes K; Makláry E; Vargha P; Janssen J; Járay J; Perner F; Geró L
Transpl Int; 1998; 11 Suppl 1():S65-8. PubMed ID: 9664946
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.
Sasaki S; Nakagawa M; Nakata T; Endo N; Miyao K; Kitamura K; Fukuyama M; Kitani T; Yamada C
Cardiology; 1997; 88(2):160-5. PubMed ID: 9096917
[TBL] [Abstract][Full Text] [Related]
16. Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).
Farnier M; Salko T; Isaacsohn JL; Troendle AJ; Dejager S; Gonasun L
Am J Cardiol; 2003 Oct; 92(7):794-7. PubMed ID: 14516878
[TBL] [Abstract][Full Text] [Related]
17. [Long-term treatment of combined hyperlipidemia with a combination of fluvastatin and fenofibrate].
Widimský J; Hulínský V; Balazovjech I; Lánská V
Vnitr Lek; 1999 Apr; 45(4):210-6. PubMed ID: 11045181
[TBL] [Abstract][Full Text] [Related]
18. [Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].
Tvorogova MG; Susekov AV; Semenova OA; Kukharchuk VV; Titov VN
Ter Arkh; 1998; 70(12):8-13. PubMed ID: 10067240
[TBL] [Abstract][Full Text] [Related]
19. Endurance training has little effect on active muscle free fatty acid, lipoprotein cholesterol, or triglyceride net balances.
Jacobs KA; Krauss RM; Fattor JA; Horning MA; Friedlander AL; Bauer TA; Hagobian TA; Wolfel EE; Brooks GA
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E656-65. PubMed ID: 16684856
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of slow-release fluvastatin 80 mg daily in Chinese patients with hypercholesterolemia.
Wu CC; Hsu TL; Chiang HT; Ding PY
J Chin Med Assoc; 2005 Aug; 68(8):353-9. PubMed ID: 16138713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
